Search

Author/Creator Modhiran, Naphak

2. Inactivation of SARS‐CoV‐2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light. Issue 2 (8th January 2023)

Authors:
Hobson‐Peters, Jody; Amarilla, Alberto A.; Rustanti, Lina; Marks, Denese C.; Roulis, Eileen; Khromykh, Alexander A.; Modhiran, Naphak; Watterson, Daniel; Reichenberg, Stefan; Tolksdorf, Frank; Sumian, Chryslain; Seltsam, Axel; Gravemann, Ute; Faddy, Helen M.
Journal:
Transfusion
Issue:
Volume 63:Issue 2(2023)
Page Start:
288
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell–cell fusion. (15th January 2021)

Authors:
Thakur, Nazia; Conceicao, Carina; Isaacs, Ariel; Human, Stacey; Modhiran, Naphak; McLean, Rebecca K.; Pedrera, Miriam; Tan, Tiong Kit; Rijal, Pramila; Townsend, Alain; Taylor, Geraldine; Young, Paul R.; Watterson, Daniel; Chappell, Keith J.; Graham, Simon P.; Bailey, Dalan
Journal:
Journal of general virology
Issue:
Volume 102:Number 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2. Issue 4 (5th April 2021)

Authors:
Watterson, Daniel; Wijesundara, Danushka K; Modhiran, Naphak; Mordant, Francesca L; Li, Zheyi; Avumegah, Michael S; McMillan, Christopher LD; Lackenby, Julia; Guilfoyle, Kate; van Amerongen, Geert; Stittelaar, Koert; Cheung, Stacey TM; Bibby, Summa; Daleris, Mallory; Hoger, Kym; Gillard, Marianne...
Journal:
Clinical & translational immunology
Issue:
Volume 10:Issue 4(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Issue 10 (October 2021)

Authors:
Chappell, Keith J; Mordant, Francesca L; Li, Zheyi; Wijesundara, Danushka K; Ellenberg, Paula; Lackenby, Julia A; Cheung, Stacey T M; Modhiran, Naphak; Avumegah, Michael S; Henderson, Christina L; Hoger, Kym; Griffin, Paul; Bennet, Jillian; Hensen, Luca; Zhang, Wuji; Nguyen, Thi H O; Marrero-Hern...
Journal:
Lancet infectious diseases
Issue:
Volume 21:Issue 10(2021)
Page Start:
1383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. SARS‐CoV‐2 triggers complement activation through interactions with heparan sulfate. Issue 8 (18th August 2022)

Authors:
Lo, Martin W; Amarilla, Alberto A; Lee, John D; Albornoz, Eduardo A; Modhiran, Naphak; Clark, Richard J; Ferro, Vito; Chhabra, Mohit; Khromykh, Alexander A; Watterson, Daniel; Woodruff, Trent M
Journal:
Clinical & translational immunology
Issue:
Volume 11:Issue 8(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern. Issue 34 (12th August 2022)

Authors:
McMillan, Christopher L.D.; Amarilla, Alberto A.; Modhiran, Naphak; Choo, Jovin J.Y.; Azuar, Armira; Honeyman, Kate E.; Khromykh, Alexander A.; Young, Paul R.; Watterson, Daniel; Muller, David A.
Journal:
Vaccine
Issue:
Volume 40:Issue 34(2022)
Page Start:
4929
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗